Investor Relations

News Releases

 
News Releases
  Date Title View
Dec 29, 2015
Cartilage Regeneration Therapy Builds Upon Company's Orthobiologics Experience, Representing Expansion into Field of Regenerative Medicine BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeuti...
Dec 9, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced that the U.S. Food & Drug Administration's (FDA) Office of Combination Products ...
Nov 19, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D...
Nov 3, 2015
Achieves First Approval for Innovative Therapy Combining Hyaluronic Acid Technology with FDA-Approved Steroid BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its prop...
Oct 29, 2015
Industry Veteran to Oversee Further Global Expansion of Commercial Platform, Strengthening of Commercial Partnerships, and Development of Direct Commercial Capability BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics ...
Oct 28, 2015
Company Achieves 37.5% Year-over-Year Diluted EPS Growth in Quarter BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, today rep...
Oct 14, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that the Company plans to issue its third-quarter 2015 financial results after the close of the market on Wednesday, October 28, 2015, and hold a conference call the next day, Thursday, October 29 at 9:00 a.m. ET to...
Aug 19, 2015
Jul 29, 2015
Strength in Quarter Driven by Continued Adoption of Orthobiologics Products; Combined ORTHOVISC® and MONOVISC® U.S. Market Share Surpasses 25% BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a leader in products for tissue protect...
Jul 15, 2015
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that the Company plans to issue its second-quarter 2015 financial results after the close of the market on Wednesday, July 29, 2015, and to hold a conference call the next day, Thursday, July 30 at 9:00 a.m. ET to d...

= add release to Briefcase